Another study showed an association between a nonsense variant at the carboxyl terminus of BRCA2 (p.Lys3326Ter) with a relative risk of breast cancer of 1.4, substantially lower than the risk conferred by more proximal truncating variants (RR = 11.7) [50]. This evidence concerns the gene BRCA2 and breast carcinoma.